Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VV-14300 for the Treatment of Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT07831798 | |
| VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT07829302 | |
| A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH) | Recruiting | Phase 1 / Phase 2 | 2026-09-01 | NCT07732400 | |
| A Study of VV-14305 for the Treatment of Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT07404111 | |
| A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration | Geographic Atrophy Secondary to Age-related Macular Degeneration | Recruiting | Phase 1 / Phase 2 | 2026-08-10 | NCT06765980 | |
| RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia | Stomatognathic Diseases, cranial nerve neuropathy, facial nerve disorder, facial neuralgia, mouth disorder, nervous system disorder, trigeminal nerve disorder, trigeminal neuralgia | Recruiting | Phase 1 / Phase 2 | 2026-06-08 | NCT07596485 |